tiprankstipranks
Relmada Therapeutics (RLMD)
NASDAQ:RLMD
Holding RLMD?
Track your performance easily

Relmada Therapeutics (RLMD) Financial Statements

302 Followers

Relmada Therapeutics Financial Overview

Relmada Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.869; its P/E ratio is -1.05; Relmada Therapeutics is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is $-0.68. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Dec 23Sep 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit----$ -83.60K
EBIT$ -21.73M$ -17.77M$ -26.83M$ -22.69M$ 29.99M
EBITDA$ -21.73M$ -17.77M$ -26.83M$ -22.69M$ 29.99M
Net Income Common Stockholders$ -21.73M$ -17.77M$ -25.17M$ -22.00M$ 29.99M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 54.12M$ 70.44M$ 96.32M$ 106.27M$ 132.44M
Total Assets$ 55.72M$ 71.03M$ 97.55M$ 109.15M$ 135.57M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -54.12M$ -70.44M$ -96.32M$ -106.27M$ -132.44M
Total Liabilities$ 8.10M$ 9.54M$ 12.19M$ 8.42M$ 10.10M
Stockholders Equity$ 47.63M$ 61.49M$ 85.36M$ 100.73M$ 125.47M
Cash Flow-
Free Cash Flow$ -16.66M$ -13.26M$ -10.25M$ -11.63M$ -16.51M
Operating Cash Flow$ -16.66M$ -13.26M$ -10.25M$ -11.63M$ -16.51M
Investing Cash Flow$ 16.14M$ 14.01M$ 7.74M$ 3.86M$ 40.00M
Financing Cash Flow$ -89.60K-$ -98.46K--
Currency in USD

Relmada Therapeutics Earnings and Revenue History

Relmada Therapeutics Debt to Assets

Relmada Therapeutics Cash Flow

Relmada Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis